Involuntary Memories Investigation in Schizophrenia
Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Jul 3, 2017
Trial Information
Current as of May 25, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - for patients only
- • male or female
- • age limits : 18-55 years old
- • under the protection of health insurance
- • who have signed up the consent form
- • schizophrenia or schizo-affective disorder according to the DSM-5 criteria (APA, 2013).
- • clinically stable for at least 2 months
- • patients under guardianship or curatorship need agreement of their legal representative
- • informed of the results of prior medical examination for controls only
- • male or female
- • age limits : 18-55 years old
- • under the protection of health insurance
- • who have sign up the consent form
- • recruited from the general population and matched on gender, age years of schooling
- • no psychiatric history (DSM-5)
- Exclusion Criteria:
- • for both patients and controls
- • current severe or unstable somatic illness
- • neurological history (brain injury \> 15 minutes loss of consciousness , epilepsia, brain surgery...)
- • current substance use disorder (DSM-5)
- • current major depressive disorder (CDSS,BDI, HDRS)
- • mental retardation (IQ \< 70, WAIS-4, f-NART)
- • history of general anesthesia 3 months prior to the experiment
- • pregnancy declared by the subject
- • breast feeding
- • current legal control
- • in emergency situation
- • included during exclusion period in another experiment
- • for controls only
- • taking of antipsychotic drugs for the 3 weeks prior to inclusion
- • under guardianship or curatorship
About University Hospital, Strasbourg, France
The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Strasbourg, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials